G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (“G Medical” or the "Company"), a Telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, ...

In the absence of PCR testing, infectious disease experts and epidemiologists are anxiously awaiting serology results from the household contact and two healthcare workers who may have been infected ...

Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...

Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope specificity, isotype, and affinity/avidity. This makes it challenging for clinical ...

The coronavirus disease 2019 (COVID-19) pandemic brought about by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already led to four major waves of infection in Canada. Reports ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Maintaining consistent assay performance over time is critical for clinical laboratories. While assay performance characteristics may be clearly understood at the time of validation, variations can ...